About

This company develops medical-grade laser light therapy devices that use photobiomodulation to stimulate cell recovery and reduce chronic pain and inflammation. Their devices target the gut microbiome, gut-brain axis, and brain to help manage symptoms of chronic conditions.

```xml <problem> Chronic conditions like Parkinson's disease, brain health issues, and general pain and inflammation often require ongoing management, but effective, non-invasive, and drug-free treatment options are limited. Existing treatments may not adequately address the underlying cellular dysfunction contributing to these conditions. </problem> <solution> SYMBYX Biome offers medical-grade laser therapy devices that utilize photobiomodulation (PBM) to stimulate cellular recovery and reduce symptoms associated with chronic conditions. These devices deliver low-level laser light to energize cells, reduce pain and inflammation, improve the gut microbiome, benefit cognitive function, and assist with tissue repair. The devices are designed for ease of use at home and are backed by extensive scientific and clinical research. SYMBYX Biome aims to provide a complementary treatment modality that works with the body's natural healing processes. </solution> <features> - Medical-grade laser devices for home use - Photobiomodulation (PBM) technology to stimulate cellular function - Specific devices tailored for Parkinson's disease, brain health, pain management, and skin care - Targets the gut microbiome, gut-brain axis, and brain - Reduces pain and inflammation - Improves cognitive function - Assists with tissue repair - Ongoing clinical support provided with every purchase - CE-marked and ARTG-listed medical devices </features> <target_audience> The primary audience includes individuals seeking non-invasive, drug-free options for managing chronic conditions such as Parkinson's disease, brain health issues, pain, and inflammation, as well as clinicians looking for complementary treatment modalities for their patients. </target_audience> ```

What does do?

This company develops medical-grade laser light therapy devices that use photobiomodulation to stimulate cell recovery and reduce chronic pain and inflammation. Their devices target the gut microbiome, gut-brain axis, and brain to help manage symptoms of chronic conditions.

0

Find Investable Startups and Competitors

Search thousands of startups using natural language

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

This company develops medical-grade laser light therapy devices that use photobiomodulation to stimulate cell recovery and reduce chronic pain and inflammation. Their devices target the gut microbiome, gut-brain axis, and brain to help manage symptoms of chronic conditions.

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Chronic conditions like Parkinson's disease, brain health issues, and general pain and inflammation often require ongoing management, but effective, non-invasive, and drug-free treatment options are limited. Existing treatments may not adequately address the underlying cellular dysfunction contributing to these conditions.

Solution

SYMBYX Biome offers medical-grade laser therapy devices that utilize photobiomodulation (PBM) to stimulate cellular recovery and reduce symptoms associated with chronic conditions. These devices deliver low-level laser light to energize cells, reduce pain and inflammation, improve the gut microbiome, benefit cognitive function, and assist with tissue repair. The devices are designed for ease of use at home and are backed by extensive scientific and clinical research. SYMBYX Biome aims to provide a complementary treatment modality that works with the body's natural healing processes.

Features

Medical-grade laser devices for home use

Photobiomodulation (PBM) technology to stimulate cellular function

Specific devices tailored for Parkinson's disease, brain health, pain management, and skin care

Targets the gut microbiome, gut-brain axis, and brain

Reduces pain and inflammation

Improves cognitive function

Assists with tissue repair

Ongoing clinical support provided with every purchase

CE-marked and ARTG-listed medical devices

Target Audience

The primary audience includes individuals seeking non-invasive, drug-free options for managing chronic conditions such as Parkinson's disease, brain health issues, pain, and inflammation, as well as clinicians looking for complementary treatment modalities for their patients.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.